期刊文献+

川崎病49例临床分析 被引量:4

下载PDF
导出
摘要 皮肤粘膜淋巴结综合征(mucocutaneous lymphonode syndrome,MCLS)又称川崎病(Kawasaki disease,KD),是一种以全身血管炎为主要病变的急性发热出疹性小儿疾病。其病因及发病机制仍未完全清楚。大量流行病学及临床观察提示,KD可能是易患宿主由多种感染病原触发的一种免疫介导的全身性血管炎。
出处 《华南国防医学杂志》 CAS 2011年第1期80-81,共2页 Military Medical Journal of South China
  • 相关文献

参考文献7

二级参考文献24

  • 1金虹 梁翊常 等.正常儿童冠状动脉超声心动图研究[J].中华儿科杂志,1988,26:257-259.
  • 2Furusho K,Kamlga T,Nakano II ,et al. High dose intraveous gamma globulin for Kawasaki disease[ J]. Lancet, 1984,2 : 1055 - 1058.
  • 3Katoch T,Jwasa K, Sygiyama K, et al. Prediction of high risk patient and effect of gamma globulin treatment in Kawasaki disease. Presented at the trird Internatioal Kawasaki Disease Symposium [ J ]. Tokyo, November29 - December2,1988, report.
  • 4KAWASAKI T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J].Jpn J Allergy,1967,16:178-222.
  • 5HAN R K,SINCAIR B,NEWMAN A,et al.Recognition and management of Kawasaki disease[J].CMAJ,2000,162(6): 807-812.
  • 6JAPAN KAWASAKI DISEASE RESEARCH COMMITTEE.Diagnostic guidelines of Kawasaki disease[Z].4th Revision.Tokyo: Kawasaki Disease Research Committee,1984.
  • 7MOMENAH T,SANATANI S,POTTS J,et al.Kawasaki disease in the older child[J].Pediatrics,1998,102: e7.
  • 8PARMAR R C,SOMALE A,BAVDEKAR S B,et al.Incomplete Kawasaki disease with recurrent skin peeling: a case report with the review of literature[J].J Postgrad Med,2003,49:72-74.
  • 9MCMASTER P,COOPER S,ISAACS D.Is it Kawasaki disease[J].J Paediatr Child Health,2000,36(5):506-508.
  • 10VIJAYALAKSHMI A M,GOMATHI V.Incomplete Kawasaki syndrome in an eighty-days-old Male infant[J].Indian Pediatrics,2002,39: 485-488.

共引文献97

同被引文献43

  • 1陈翔.浅谈小儿川崎病的护理体会[J].求医问药(下半月),2013(4):229-229. 被引量:1
  • 2张乾忠.不典型川崎病的临床表现和诊断[J].中国实用儿科杂志,2006,21(10):728-730. 被引量:118
  • 3张永兰,杜忠东.小儿川崎病冠状动脉损伤的危险因素[J].中国实用儿科杂志,2006,21(10):742-744. 被引量:48
  • 4Honkanen V E, MeCrindle B W, Laxer R M, et al. Clinical relevance of the risk factory for coronary artery inflammation in Kawasaki disease [ J ]. Pediatr Cardiol, 2003, 24 ( 2 ) : 122.
  • 5Gundogda F, Bozkurt E, Kizihune A, et al. The effect of betablocker (carvedilol) therapy on N - terminal por- brain natriuertic peptid levels and eehocardiographie findings in patients with eongestiveheart failure [ J ]. Echocardiography, 2007, 24(2): 113.
  • 6Kawamura T, Wago M, Kawaguchi H, et al. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease[J]. Pediatr Int, 2000, 42: 241.
  • 7Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnistie guidelines for Kawasaki disease(the 5th revised edtion)[J]. pediatr Int, 2005, 47:232.
  • 8吴瑞萍,胡亚关,江载芳.实用儿科学[M].人民卫生出版社,2002:687.
  • 9NAKAMURA Y, YASHIRO M, UEHARA R, et al. Epidemiolog- ic features of Kawasaki disease in Japan: results of the 2007 2008 nationwide survey[J]. Epidemiol, 2010, 20 (4): 302.
  • 10AYUSAWA M,SONOHE T, UEMURA S, et al. Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasa- ki disease (the 5th revised edition) [ J ]. Pediatrics International, 2005,47(2) ;232 -234.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部